Meta‐analysis of clinical metabolic profiling studies in cancer: challenges and opportunities

Cancer cell metabolism has received increasing attention. Despite a boost in the application of clinical metabolic profiling (CMP) in cancer patients, a meta‐analysis has not been performed. The primary goal of this study was to assess whether public accessibility of metabolomics data and identification and reporting of metabolites were sufficient to assess which metabolites were consistently altered in cancer patients. We therefore retrospectively curated data from CMP studies in cancer patients published during 5 recent years and used an established vote‐counting method to perform a semiquantitative meta‐analysis of metabolites in tumor tissue and blood. This analysis confirmed well‐known increases in glycolytic metabolites, but also unveiled unprecedented changes in other metabolites such as ketone bodies and amino acids (histidine, tryptophan). However, this study also highlighted that insufficient public accessibility of metabolomics data, and inadequate metabolite identification and reporting hamper the discovery potential of meta‐analyses of CMP studies, calling for improved standardization of metabolomics studies.

[1]  R. Mohammad,et al.  Measurement of 1,5-anhydroglucitol in blood and saliva: from non-targeted metabolomics to biochemical assay , 2016, Journal of Translational Medicine.

[2]  Frank B Hu,et al.  Metabolomics in Prediabetes and Diabetes: A Systematic Review and Meta-analysis , 2016, Diabetes Care.

[3]  Martin Offringa,et al.  Systematic reviews and meta-analysis. , 2015, Seminars in fetal & neonatal medicine.

[4]  Matej Oresic,et al.  Data standards can boost metabolomics research, and if there is a will, there is a way , 2015, Metabolomics.

[5]  P. Schuetz,et al.  Systematic review regarding metabolic profiling for improved pathophysiological understanding of disease and outcome prediction in respiratory infections , 2015, Respiratory Research.

[6]  U. Sauer,et al.  Biological insights through nontargeted metabolomics. , 2015, Current opinion in biotechnology.

[7]  F. Hirsch,et al.  Independent validation test of the vote-counting strategy used to rank biomarkers from published studies. , 2015, Biomarkers in medicine.

[8]  Matej Oresic,et al.  COordination of Standards in MetabOlomicS (COSMOS): facilitating integrated metabolomics data access , 2015, Metabolomics.

[9]  Nozomu Sakurai,et al.  Metabolonote: A Wiki-Based Database for Managing Hierarchical Metadata of Metabolome Analyses , 2015, Front. Bioeng. Biotechnol..

[10]  Christoph Steinbeck,et al.  Data standards can boost metabolomics research , 2015 .

[11]  J. Huynh,et al.  A systematic review of metabolite profiling in gestational diabetes mellitus , 2014, Diabetologia.

[12]  Ian D Wilson,et al.  LC-MS-based holistic metabolic profiling. Problems, limitations, advantages, and future perspectives. , 2014, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[13]  R. Powers,et al.  Metabolic reprogramming induced by ketone bodies diminishes pancreatic cancer cachexia , 2014, Cancer & metabolism.

[14]  T. Seyfried,et al.  Ketone supplementation decreases tumor cell viability and prolongs survival of mice with metastatic cancer , 2014, International journal of cancer.

[15]  V. Mootha,et al.  Metabolic enzyme expression highlights a key role for MTHFD2 and the mitochondrial folate pathway in cancer , 2014, Nature Communications.

[16]  G. Hanna,et al.  Metabolomic profiling of oesophago-gastric cancer: a systematic review. , 2013, European journal of cancer.

[17]  Christoph Steinbeck,et al.  The role of reporting standards for metabolite annotation and identification in metabolomic studies , 2013, GigaScience.

[18]  H. Jiang,et al.  Potential role of proteomics in the diagnosis of lymphoma: a meta‐analysis , 2013, International journal of laboratory hematology.

[19]  D. Vitkup,et al.  Heterogeneity of tumor-induced gene expression changes in the human metabolic network , 2013, Nature Biotechnology.

[20]  Sean R. Davis,et al.  NCBI GEO: archive for functional genomics data sets—update , 2012, Nucleic Acids Res..

[21]  Christoph Steinbeck,et al.  MetaboLights—an open-access general-purpose repository for metabolomics studies and associated meta-data , 2012, Nucleic Acids Res..

[22]  David Broadhurst,et al.  The importance of experimental design and QC samples in large-scale and MS-driven untargeted metabolomic studies of humans. , 2012, Bioanalysis.

[23]  William E. Kraus,et al.  Metabolomic Profiling for the Identification of Novel Biomarkers and Mechanisms Related to Common Cardiovascular Diseases: Form and Function , 2012, Circulation.

[24]  G. Siuzdak,et al.  Innovation: Metabolomics: the apogee of the omics trilogy , 2012, Nature Reviews Molecular Cell Biology.

[25]  M. Weller,et al.  An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor , 2011, Nature.

[26]  M. V. Vander Heiden,et al.  Aerobic glycolysis: meeting the metabolic requirements of cell proliferation. , 2011, Annual review of cell and developmental biology.

[27]  Brian J. Bennett,et al.  Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease , 2011, Nature.

[28]  G. Bhagat,et al.  Histamine deficiency promotes inflammation-associated carcinogenesis through reduced myeloid maturation and accumulation of CD11b+Ly6G+ immature myeloid cells , 2010, Nature Medicine.

[29]  Jenny Forshed,et al.  Multivariate meta-analysis of proteomics data from human prostate and colon tumours , 2010, BMC Bioinformatics.

[30]  A. Tsirigos,et al.  Ketones and lactate “fuel” tumor growth and metastasis , 2010, Cell cycle.

[31]  L. Liau,et al.  Cancer-associated IDH1 mutations produce 2-hydroxyglutarate , 2009, Nature.

[32]  L. Cantley,et al.  Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation , 2009, Science.

[33]  Ola Larsson,et al.  Lack of correct data format and comparability limits future integrative microarray research , 2006, Nature Biotechnology.

[34]  Lennart Martens,et al.  PRIDE: a public repository of protein and peptide identifications for the proteomics community , 2005, Nucleic Acids Res..

[35]  Sergio Contrino,et al.  ArrayExpress—a public repository for microarray gene expression data at the EBI , 2004, Nucleic Acids Res..

[36]  A. Fernie,et al.  Metabolite profiling: from diagnostics to systems biology , 2004, Nature Reviews Molecular Cell Biology.

[37]  M. Medina,et al.  Glutamine and cancer. , 2001, The Journal of nutrition.

[38]  K. Fearon,et al.  Cancer cachexia. , 1999, Surgical oncology.

[39]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .

[40]  W W Souba,et al.  Glutamine and Cancer , 1993, Annals of surgery.

[41]  the original work is properly cited. , 2022 .